Interestingly, the usage of TNFα antagonists has been reported in several case studies to be associated with GBS pathogenesis; the exact mechanism is not fully known, but it is thought that TNFα antagonists may be causing increased susceptibility to latent infections, thereby making the autoimmune process worse [68,69]. Here, TNF is linked to Guillain-Barre syndrome.